Sanofi-Aventis And Regeneron Update Aflibercept (VEGF Trap) Clinical Development Program In Oncology

Sanofi-Aventis (Euronext: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) provided an update on the clinical development program for aflibercept, including results from a Phase 2 study in advanced ovarian cancer.

More: continued here

Filed under: Cancer on May 22nd, 2008

Comments are closed.

« Farm Bill’s New Tax Credit For Biofuel Production Will Support Development Of Advanced Low-Carbon Biofuels Surgery Not Responsible For Long-Term Cognitive Decline In Bypass Patients »

Pills Store Online - Buy Drugs: Pills sotre online
Quality Generic Pills - : Quality Generic Pills
RX Hint - Information and products: Find more details about Rx products only by entering.
Soma Drugs - Soma Pills: Soma is a muscle relaxant used to relieve the pain and stiffness of muscle.
Zanaflex Online - Buy Drugs: Order Zanaflex
Discount prescripts - : Discount prescripts
Drug store online - Drug store online: Pills form drugs store online
Medical rx pill - : Medical rx pill
Prescript Medicine - : Prescript Medicine
Rx store online - : Rx store online
Travellers pharmacy - : Pharmacy for people that travel
Latest News...